Related Experiment Video
Updated: Jan 29, 2026

P50 Sensory Gating in Infants
Published on: December 26, 2013
The prevention of severe pertussis and pertussis deaths in young infants
1a Department of Pediatrics , David Geffen School of Medicine at UCLA , Los Angeles , CA , USA.
Insights
Preventing infant deaths from pertussis (whooping cough) requires maternal Tdap immunization and treating infected adults. Exchange blood transfusions can help infants if initiated before organ failure, addressing pertussis toxin-induced pulmonary hypertension.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Pertussis (whooping cough) primarily causes infant mortality in developed nations.
- Infant pertussis presents as afebrile cough, coryza, apnea, seizures, cyanosis, and emesis.
- Severe cases involve high leukocyte/lymphocyte counts, rapid vitals, and pneumonia, with some intensive care treatments being detrimental.
Purpose of the Study:
- To outline the characteristics and management of pertussis in young infants.
- To discuss the pathophysiology of severe pertussis and its treatment.
- To recommend preventative strategies for pertussis in neonates.
Main Methods:
- Review of clinical presentation and outcomes of Bordetella pertussis in infants.
- Analysis of the role of pertussis toxin in infant mortality.
- Evaluation of current and proposed preventative measures, including maternal immunization and antimicrobial prophylaxis.
Main Results:
- Infant deaths are attributed to pertussis toxin-induced pulmonary hypertension from leukocyte aggregates.
- High leukocyte and lymphocyte counts are key indicators of severe pertussis.
- Exchange blood transfusions are effective if started before shock or organ failure.
Conclusions:
- Maternal Tdap immunization between 27-36 weeks gestation is crucial for preventing infant pertussis.
- Diagnosing and treating pertussis in adolescents and adults is vital for infant protection.
- Antimicrobial prophylaxis for infants and Tdap vaccination during all pregnancies are recommended preventative strategies.
Introduction:
Today, in the developed world, virtually all deaths due to Bordetella pertussis illnesses occur in young infants. Areas Covered: Pertussis in young infants is characterized by an afebrile cough illness with coryza, apnea, seizures, cyanosis, and emesis. Severe illness is associated with high leukocyte and lymphocyte counts, rapid respiratory and cardiac rates and pneumonia. Many routine intensive care treatment procedures are detrimental: these include steroids and nitric oxide. Preventative measures include: quarantine, prophylactic antimicrobial agents and immunizations of the mother to be with Tdap between 27 and 36 weeks gestation. Expert Opinion: Infants deaths are due to the irreversible pulmonary hypertension which is caused by aggregates of leukocytes in the small vessels in the lung. The leukocytosis with lymphocytosis is due to pertussis toxin. It can be treated by exchange blood transfusions. However for this to be successful it needs to be started before shock or organ failure has occurred. To prevent pertussis in young infants, attention needs to be directed to the diagnosis and treatment of pertussis in adolescents and adults. Also important are antimicrobial prophylaxis in the infant and the immunization of mothers to be with Tdap vaccine during all pregnancies.
Related Concept Videos
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Drug Dosing: Infants and Children
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

